101
Views
3
CrossRef citations to date
0
Altmetric
Review

Role of brentuximab vedotin in the treatment of relapsed or refractory Hodgkin lymphoma

, &
Pages 79-85 | Published online: 20 Feb 2014

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.